WEBINAR: Fit-for-purpose RWD: An integral part of evidence planning – VIEW ON DEMAND
VIEW ON DEMAND!
Navigating the evolving landscape of real-world evidence: Strategies for effective integrated evidence planning in life sciences
Evidence planners in the life sciences are increasingly adopting Integrated Evidence Planning (IEP) to meet the diverse needs of stakeholders, with real-world evidence (RWE) being vital for demonstrating the safety and value of products beyond traditional clinical trials. The emergence of new global data sources, such as patient registries and electronic health records, complicates the selection of appropriate real-world data (RWD) for research objectives.
In this webinar, our experts explore the expanding RWD landscape, discuss challenges in RWE study design, and provide strategies for selecting the right data while addressing critical factors like data quality and regulatory compliance.
Speakers
Dana Stafkey, PharmD, PhD
Vice-President, Real-World Evidence, Cencora
In this role, Dana leads a team of researchers conducing both retrospective and prospective studies to generate real-world evidence to support various stakeholders including payers, regulators, physicians, and patients. Dr Stafkey has over 20 years of experience leading and conducting real-world evidence studies for pharmaceutical, biotechnology, and medical device companies. She has extensive experience in the design and analysis of studies using retrospective health care claims data, electronic medical records, customized medical chart abstraction data, cross-sectional and longitudinal survey data and inpatient care data, as well as prospective data collection. Her research has encompassed a wide variety of therapeutic areas, including oncology, hematology, mental health disorders, neurological disorder, infectious disease, cardiovascular diseases, endocrine disorders, and musculoskeletal disorders. Dr. Stafkey has co-authored research published in a variety of peer-reviewed journals, including Annals of Pharmacotherapy, Value in Health, Psychiatric Services, and Journal of Oncology Practice and regularly presents her work at national and international meetings. Dr Stafkey has a Doctor of Pharmacy from the University of South Carolina, completed a Health Outcomes and Pharmacoeconomics fellowship at the University of Michigan and Pfizer, Inc., and received her PhD in Pharmaceutical Economics and Policy from the University of Southern California.
Tasneem Lokhandwala, BPharm, MS, PhD
Senior Director, Real-World Evidence, Cencora
In this role, Tasneem serves as the strategic oversight and subject matter expert on research that utilizes primary or secondary real-world data to generate evidence supporting discussions with payer, provider, patient group, and regulatory stakeholders. She has 12+ years of experience in study design, procuring/curating real-world data, analyses, and the dissemination of such research. Her work has led to 15+ manuscript publications in leading peer-reviewed journals such as Clinical Lung Cancer and Clinical Therapeutics, 50+ poster presentations at national and international meetings, and media engagements. Her experience spans over a variety of therapeutic areas including rare and orphan diseases, and she has worked with numerous EMR/EHR, patient charts, clinical trial, and claims data sources. Dr Lokhandwala received her PhD and MS in Pharmacy Administration from the University of Mississippi and is originally from Mumbai, India, where she completed her Bachelors in Pharmaceutical Sciences (BPharm) from Mumbai University.
Henri Leleu, MD, MPH, PhD
Senior Scientific Director, Real-World Evidence, cencora
Dr Henri Leleu is a medical doctor specialized in public health and holds a PhD in health economics. Co-founder of Public Health Expertise (PHE), he has over 15 years in public health in the fields of epidemiology, health economy, health care organization, health innovation and methodology. He is an expert in health care simulations with over 20 simulation models developed in wide range of diseases.
Published as part of the Evidence Insights, "Turning data into evidence: fit-for-purpose RWD in practice", sponsored by Cencora.